{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T15:43:41Z","timestamp":1779205421167,"version":"3.51.4"},"reference-count":56,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T00:00:00Z","timestamp":1700784000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Saudi Journal of Biological Sciences"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.sjbs.2023.103884","type":"journal-article","created":{"date-parts":[[2023,11,25]],"date-time":"2023-11-25T11:48:09Z","timestamp":1700912889000},"page":"103884","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Designing of fragment based inhibitors with improved activity against E. coli AmpC \u03b2-lactamase compared to the conventional antibiotics"],"prefix":"10.1016","volume":"31","author":[{"given":"Sidrah","family":"Hafeez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rehan","family":"Zafar Paracha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fazal","family":"Adnan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.sjbs.2023.103884_b0005","doi-asserted-by":"crossref","first-page":"4249","DOI":"10.2147\/IDR.S284751","article-title":"Plasmid-mediated AmpC \u03b2-lactamase CITM and DHAM genes among gram-negative clinical isolates","author":"Aryal","year":"2020","journal-title":"Infect. Drug Resist."},{"key":"10.1016\/j.sjbs.2023.103884_b0010","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1080\/00325481.2019.1680052","article-title":"Treatment of urinary tract infections in the era of antimicrobial resistance and new antimicrobial agents","volume":"132","author":"Bader","year":"2020","journal-title":"Postgrad. Med."},{"key":"10.1016\/j.sjbs.2023.103884_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2020.104117","article-title":"Evaluation of acridinedione analogs as potential SARS-CoV-2 main protease inhibitors and their comparison with repurposed anti-viral drugs","volume":"128","author":"Bhardwaj","year":"2021","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.sjbs.2023.103884_b0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12879-018-2960-9","article-title":"Empiric antibiotic therapy in urinary tract infection in patients with risk factors for antibiotic resistance in a German emergency department","volume":"18","author":"Bischoff","year":"2018","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.sjbs.2023.103884_b0025","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.1128\/JCM.43.7.3110-3113.2005","article-title":"AmpC disk test for detection of plasmid-mediated AmpC \u03b2-lactamases in Enterobacteriaceae lacking chromosomal AmpC \u03b2-lactamases","volume":"43","author":"Black","year":"2005","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.sjbs.2023.103884_b0030","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/nature09454","article-title":"Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma","volume":"467","author":"Bollag","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.sjbs.2023.103884_b0035","doi-asserted-by":"crossref","first-page":"12857","DOI":"10.3390\/ijms131012857","article-title":"Fragment-based screening by protein crystallography: successes and pitfalls","volume":"13","author":"Chilingaryan","year":"2012","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.sjbs.2023.103884_b0040","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3390\/antibiotics7010014","article-title":"Fragment-based discovery of inhibitors of the bacterial DnaG-SSB interaction","volume":"7","author":"Chilingaryan","year":"2018","journal-title":"Antibiotics"},{"key":"10.1016\/j.sjbs.2023.103884_b0045","doi-asserted-by":"crossref","first-page":"3733","DOI":"10.1080\/07391102.2020.1771424","article-title":"Fragment tailoring strategy to design novel chemical entities as potential binders of novel corona virus main protease","volume":"39","author":"Choudhury","year":"2021","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.sjbs.2023.103884_b0050","doi-asserted-by":"crossref","first-page":"3481","DOI":"10.1080\/07391102.2020.1847687","article-title":"Development of parameters compatible with the CHARMM36 force field for [Fe4S4] 2+ clusters and molecular dynamics simulations of adenosine-5\u2019-phosphosulfate reductase in GROMACS 2019","volume":"40","author":"Da Silva","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.sjbs.2023.103884_b0055","doi-asserted-by":"crossref","first-page":"17448","DOI":"10.1073\/pnas.1208337109","article-title":"Fragment-guided design of subnanomolar \u03b2-lactamase inhibitors active in vivo","volume":"109","author":"Eidam","year":"2012","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.sjbs.2023.103884_b0060","first-page":"181","article-title":"Multidrug resistant AmpC \u03b2-lactamase producing Escherichia coli isolated from a paediatric hospital","volume":"30","author":"Ejaz","year":"2014","journal-title":"Pak. J. Med. Sci."},{"key":"10.1016\/j.sjbs.2023.103884_b0065","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/nrd.2016.109","article-title":"Twenty years on: the impact of fragments on drug discovery","volume":"15","author":"Erlanson","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.sjbs.2023.103884_b0070","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1021\/cr030102i","article-title":"Bacterial resistance to \u03b2-lactam antibiotics: compelling opportunism, compelling opportunity","volume":"105","author":"Fisher","year":"2005","journal-title":"Chem. Rev."},{"key":"10.1016\/j.sjbs.2023.103884_b0075","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.cmi.2015.12.002","article-title":"The negative impact of antibiotic resistance","volume":"22","author":"Friedman","year":"2016","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.sjbs.2023.103884_b0080","doi-asserted-by":"crossref","unstructured":"Gales, A. C., Jones, R. N., Gordon, K. A., Sader, H. S., Wilke, W. W., Beach, M. L., Pfaller, M. A., Doern, G. V. & Sentry Study Group Latin America, T. 2000. Activity and spectrum of 22 antimicrobial agents tested against urinary tract infection pathogens in hospitalized patients in Latin America: report from the second year of the SENTRY antimicrobial surveillance program (1998). J. Antimicrob. Chemother. 45, 295-303.","DOI":"10.1093\/jac\/45.3.295"},{"key":"10.1016\/j.sjbs.2023.103884_b0085","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1007\/s10096-016-2683-z","article-title":"Emergence of co-production of plasmid-mediated AmpC beta-lactamase and ESBL in cefoxitin-resistant uropathogenic Escherichia coli","volume":"35","author":"Ghosh","year":"2016","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.sjbs.2023.103884_b0090","doi-asserted-by":"crossref","first-page":"4334","DOI":"10.1080\/07391102.2020.1776157","article-title":"Identification of potential natural inhibitors of SARS-CoV2 main protease by molecular docking and simulation studies","volume":"39","author":"Gupta","year":"2021","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.sjbs.2023.103884_b0095","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3389\/fmicb.2014.00053","article-title":"Emergence of Escherichia coli producing extended-spectrum AmpC \u03b2-lactamases (ESAC) in animals","volume":"5","author":"Haenni","year":"2014","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.sjbs.2023.103884_b0100","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.neuron.2018.08.011","article-title":"Molecular dynamics simulation for all","volume":"99","author":"Hollingsworth","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.sjbs.2023.103884_b0105","doi-asserted-by":"crossref","unstructured":"Hubbard, R. E. & Haider, M. K. 2010. Hydrogen bonds in proteins: role and strength. eLS.","DOI":"10.1002\/9780470015902.a0003011.pub2"},{"key":"10.1016\/j.sjbs.2023.103884_b0110","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","article-title":"VMD: visual molecular dynamics","volume":"14","author":"Humphrey","year":"1996","journal-title":"J. Mol. Graph."},{"key":"10.1016\/j.sjbs.2023.103884_b0115","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.1021\/jz501780a","article-title":"Building water models: a different approach","volume":"5","author":"Izadi","year":"2014","journal-title":"J. Phys. Chem. Lett."},{"key":"10.1016\/j.sjbs.2023.103884_b0120","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1128\/CMR.00036-08","article-title":"AmpC \u03b2-lactamases","volume":"22","author":"Jacoby","year":"2009","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.sjbs.2023.103884_b0125","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.molimm.2019.02.007","article-title":"Urinary tract infection: Pathogenicity, antibiotic resistance and development of effective vaccines against Uropathogenic Escherichia coli","volume":"108","author":"Karam","year":"2019","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.sjbs.2023.103884_b0130","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/347631a0","article-title":"Molecular dynamics simulations in biology","volume":"347","author":"Karplus","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.sjbs.2023.103884_b0135","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1080\/17460441.2021.1905629","article-title":"What makes a good fragment in fragment-based drug discovery?","volume":"16","author":"Konteatis","year":"2021","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.sjbs.2023.103884_b0140","series-title":"Novel Antimicrobial Therapies (NATs)","article-title":"Facing the Upcoming of Multidrug-Resistant and Extensively Drug-Resistant Bacteria","author":"Le\u00f3n-Buitimea","year":"2021"},{"key":"10.1016\/j.sjbs.2023.103884_b0145","doi-asserted-by":"crossref","first-page":"180","DOI":"10.3389\/fmolb.2020.00180","article-title":"Application of fragment-based drug discovery to versatile targets","volume":"7","author":"Li","year":"2020","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.sjbs.2023.103884_b0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112829","article-title":"\u03b2-lactam antibiotics: An overview from a medicinal chemistry perspective","volume":"208","author":"Lima","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.sjbs.2023.103884_b0155","doi-asserted-by":"crossref","unstructured":"Mann, R., Mediati, D. G., Duggin, I. G., Harry, E. J. & Bottomley, A. L. 2017. Metabolic adaptations of uropathogenic E. coli in the urinary tract. Front. Cell. Infect. Microbiol., 7, 241.","DOI":"10.3389\/fcimb.2017.00241"},{"key":"10.1016\/j.sjbs.2023.103884_b0160","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1021\/acs.jcim.7b00190","article-title":"PlayMolecule ProteinPrepare: a web application for protein preparation for molecular dynamics simulations","volume":"57","author":"Mart\u00ednez-Rosell","year":"2017","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.sjbs.2023.103884_b0165","doi-asserted-by":"crossref","first-page":"9422","DOI":"10.1002\/anie.201603074","article-title":"Fragment linking and optimization of inhibitors of the aspartic protease endothiapepsin: fragment-based drug design facilitated by dynamic combinatorial chemistry","volume":"55","author":"Mondal","year":"2016","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.sjbs.2023.103884_b0170","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.bmc.2007.10.075","article-title":"Structure-based optimization of cephalothin-analogue boronic acids as \u03b2-lactamase inhibitors","volume":"16","author":"Morandi","year":"2008","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.sjbs.2023.103884_b0175","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1039\/C9MD90044F","article-title":"A successful collaboration between academia, biotech and pharma led to discovery of erdafitinib, a selective FGFR inhibitor recently approved by the FDA","volume":"10","author":"Murray","year":"2019","journal-title":"MedChemComm"},{"key":"10.1016\/j.sjbs.2023.103884_b0180","doi-asserted-by":"crossref","first-page":"413","DOI":"10.4155\/fmc.14.10","article-title":"Fragment-based inhibitor discovery against \u03b2-lactamase","volume":"6","author":"Nichols","year":"2014","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.sjbs.2023.103884_b0185","unstructured":"O\u2019neill, J. 2014. Review on antimicrobial resistance. Antimicrobial resistance: tackling a crisis for the health and wealth of nations, 2014."},{"key":"10.1016\/j.sjbs.2023.103884_b0190","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.ijmm.2010.04.005","article-title":"Resistance to cephalosporins and carbapenems in Gram-negative bacterial pathogens","volume":"300","author":"Pfeifer","year":"2010","journal-title":"Int. J. Med. Microbiol."},{"key":"10.1016\/j.sjbs.2023.103884_b0195","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1586\/eri.12.110","article-title":"Extraintestinal pathogenic Escherichia coli: an update on antimicrobial resistance, laboratory diagnosis and treatment","volume":"10","author":"Pitout","year":"2012","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"10.1016\/j.sjbs.2023.103884_b0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12879-021-06036-4","article-title":"Virulence genes and phylogenetic groups of uropathogenic Escherichia coli isolates from patients with urinary tract infection and uninfected control subjects: a case-control study","volume":"21","author":"Rezatofighi","year":"2021","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.sjbs.2023.103884_b0205","doi-asserted-by":"crossref","first-page":"5466","DOI":"10.1021\/acs.jpcb.7b11734","article-title":"Biomolecular simulations under realistic macroscopic salt conditions","volume":"122","author":"Ross","year":"2018","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.sjbs.2023.103884_b0210","article-title":"Prevalence of AmpC \u03b2-lactamase in clinical isolates of Escherichia coli, Klebsiella spp., and Proteus mirabilis in a Tertiary Hospital in Tehran, Iran. Jundishapur","volume":"9","author":"Saffar","year":"2016","journal-title":"J. Microbiol."},{"key":"10.1016\/j.sjbs.2023.103884_b0215","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.sajb.2021.02.007","article-title":"Bioassay-guided isolation of a new cytotoxic ceramide from Cyperus rotundus L","volume":"139","author":"Samra","year":"2021","journal-title":"S. Afr. J. Bot."},{"key":"10.1016\/j.sjbs.2023.103884_b0220","doi-asserted-by":"crossref","unstructured":"Shrestha, P., Cooper, B. S., Coast, J., Oppong, R., Do Thi Thuy, N., Phodha, T., Celhay, O., Guerin, P. J., Wertheim, H. & Lubell, Y. 2018. Enumerating the economic cost of antimicrobial resistance per antibiotic consumed to inform the evaluation of interventions affecting their use. Antimicrobial Resistance & Infection Control, 7, 1-9.","DOI":"10.1186\/s13756-018-0384-3"},{"key":"10.1016\/j.sjbs.2023.103884_b0225","doi-asserted-by":"crossref","first-page":"12763","DOI":"10.1038\/s41598-020-69431-y","article-title":"Virtual screening identifies broad-spectrum \u03b2-lactamase inhibitors with activity on clinically relevant serine-and metallo-carbapenemases","volume":"10","author":"Spyrakis","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.sjbs.2023.103884_b0230","doi-asserted-by":"crossref","first-page":"382","DOI":"10.3201\/eid0703.017303","article-title":"PulseNet: the molecular subtyping network for foodborne bacterial disease surveillance, United States","volume":"7","author":"Swaminathan","year":"2001","journal-title":"Emerging Infectious Diseases"},{"key":"10.1016\/j.sjbs.2023.103884_b0235","doi-asserted-by":"crossref","first-page":"485","DOI":"10.11622\/smedj.2016153","article-title":"Urinary tract infections in adults","volume":"57","author":"Tan","year":"2016","journal-title":"Singapore Med. J."},{"key":"10.1016\/j.sjbs.2023.103884_b0240","doi-asserted-by":"crossref","first-page":"7455","DOI":"10.1073\/pnas.0813029106","article-title":"Docking for fragment inhibitors of AmpC \u03b2-lactamase","volume":"106","author":"Teotico","year":"2009","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.sjbs.2023.103884_b0245","doi-asserted-by":"crossref","first-page":"16082","DOI":"10.1021\/bi981210f","article-title":"Three-Dimensional Structure of AmpC \u03b2-Lactamase from Escherichia c oli Bound to a Transition-State Analogue: Possible Implications for the Oxyanion Hypothesis and for Inhibitor Design","volume":"37","author":"Usher","year":"1998","journal-title":"Biochemistry"},{"key":"10.1016\/j.sjbs.2023.103884_b0250","series-title":"Chemistry and Pharmacology of \u03b2-Lactam Analogs","author":"Vaidya","year":"2017"},{"key":"10.1016\/j.sjbs.2023.103884_b0255","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/jcc.21367","article-title":"CHARMM general force field: A force field for drug-like molecules compatible with the CHARMM all-atom additive biological force fields","volume":"31","author":"Vanommeslaeghe","year":"2010","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.sjbs.2023.103884_b0260","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.2174\/156802608786786624","article-title":"Medicinal chemistry and the molecular operating environment (MOE): application of QSAR and molecular docking to drug discovery","volume":"8","author":"Vilar","year":"2008","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.sjbs.2023.103884_b0265","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1093\/bioinformatics\/bts310","article-title":"DoGSiteScorer: a web server for automatic binding site prediction, analysis and druggability assessment","volume":"28","author":"Volkamer","year":"2012","journal-title":"Bioinformatics"},{"key":"10.1016\/j.sjbs.2023.103884_b0270","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1021\/jp211054u","article-title":"Protein dynamics in organic media at varying water activity studied by molecular dynamics simulation","volume":"116","author":"Wedberg","year":"2012","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.sjbs.2023.103884_b0275","doi-asserted-by":"crossref","unstructured":"Weiner, L. M., Webb, A. K., Limbago, B., Dudeck, M. A., Patel, J., Kallen, A. J., Edwards, J. R. & Sievert, D. M. 2016. Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2011\u20132014. infection control & hospital epidemiology, 37, 1288-1301.","DOI":"10.1017\/ice.2016.174"},{"key":"10.1016\/j.sjbs.2023.103884_b0280","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1021\/acs.jctc.0c01004","article-title":"General theory of fragment linking in molecular design: why fragment linking rarely succeeds and how to improve outcomes","volume":"17","author":"Yu","year":"2020","journal-title":"J. Chem. Theory Comput."}],"container-title":["Saudi Journal of Biological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1319562X23003297?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1319562X23003297?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T17:31:23Z","timestamp":1761154283000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1319562X23003297"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S1319562X23003297"],"URL":"https:\/\/doi.org\/10.1016\/j.sjbs.2023.103884","relation":{},"ISSN":["1319-562X"],"issn-type":[{"value":"1319-562X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Designing of fragment based inhibitors with improved activity against E. coli AmpC \u03b2-lactamase compared to the conventional antibiotics","name":"articletitle","label":"Article Title"},{"value":"Saudi Journal of Biological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sjbs.2023.103884","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V. on behalf of King Saud University.","name":"copyright","label":"Copyright"}],"article-number":"103884"}}